U.S. Medical Equipment Stock News

We feel now is a pretty good time to analyse Solana Company's ( NASDAQ:HSDT ) business as it appears the company may be...

Quite a few Neurogene Inc. ( NASDAQ:NGNE ) insiders sold their shares over the past year, which may be a cause for...

Some Sprinklr, Inc. ( NYSE:CXM ) shareholders may be a little concerned to see that the President, Rory Read, recently...

When Washington talks about tariffs of up to 500% on Russian goods and fresh penalties on countries that keep buying its oil and gas, it throws global money flows into question. That kind of uncertainty often pushes investors toward alternative systems for moving value, recording trades and settling transactions. This article walks through three crypto and blockchain focused stocks from our curated screener that tap directly into that story. The three stocks below are just a sample. The full...

Sezzle recently reported its largest quarterly net subscriber gain since launching its subscription program, adding 140,000 net new subscribers through higher marketing spend that still kept subscriber payback periods under six months. The mix of aggressive yet measured marketing outlay, with management now planning to dial back core spend based on realized payback, highlights how Sezzle is using subscriber economics rather than headline volume to guide growth decisions. We will now examine...

Corporación América Airports reported August 2026 operating figures, with 7,871,000 passengers, 29,000 tons of cargo, and 75,000 aircraft movements, alongside year to date volumes of 58,294,000 passengers, 255,000 tons of cargo, and 573,000 aircraft movements compared with the same period in 2025. The contrast between slightly softer August activity and higher year to date passenger and cargo throughput gives investors a clearer view of underlying demand resilience across the airport...

ScanSource is attracting fresh attention after a period of strong price momentum that aligns with cash flow based valuation work and a focus on recurring technology and communications solutions for channel partners. The combination of upward earnings estimate revisions, a Momentum Score of B and a valuation below a discounted cash flow fair value estimate is drawing interest to how efficiently ScanSource converts its operating position into long term cash generation. This article explores...

YETI Holdings reaffirmed its 2026 outlook with expected sales growth of 7% to 8% and detailed a plan to expand products and geography through 2030. The company is pairing this growth framework with a focus on free cash flow, selective acquisitions, and share repurchases. This gives investors clearer visibility into how future cash generation could be deployed. We will now look at how YETI Holdings' reiterated 2026 sales guidance and long term plan could reshape the broader investment...

Exponent (EXPO) has attracted fresh attention after recent share price moves left the consulting firm trading well below some estimates of intrinsic value, putting its science focused business model back under the microscope for investors. Recent trading tells a mixed story for Exponent. The 90 day share price return of 20.06% points to improving momentum, even though the 30 day share price return declined 2.30%. Meanwhile, the 5 year total shareholder return fell 39.05%, showing long term...

Honeywell International unit Honeywell Technologies completed a modernized LenelS2 OnGuard access control rollout for U.S. Marine Corps barracks, supporting Barracks 2030 with centralized management for more than 70,000 locks and compliance with Department of Defense cybersecurity standards. The Marine Corps reports around 80% lower labor costs and about 60% lower material costs versus legacy approaches, illustrating how Honeywell International’s access control platform can materially...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Thermo Fisher Scientific recently raised its 2026 revenue and adjusted EPS outlook after reporting 5% organic growth and 13% adjusted EPS growth in the second quarter, supported by stronger pharma and biotech demand. The newly formed Precure collaboration with Mayo Clinic aims to combine proteomic, genomic, and clinical data for early disease detection, which deepens Thermo Fisher Scientific's role in large scale healthcare data generation. This article examines how Thermo Fisher...

KeyCorp reported second quarter 2026 earnings with a 26% year-over-year rise, supported by commercial loan growth, a wider net interest margin, $340 million of share repurchases, and the planned acquisition of Clearwater UK, alongside higher full year guidance. The combination of stronger profitability metrics, active capital returns, and an expansion of its middle market advisory franchise provides additional detail on how KeyCorp is seeking to build a more diversified earnings mix. We will...

Space Exploration Technologies has climbed sharply over the past few weeks, and the question now is whether a business this capital intensive is priced in line with the strength of its balance sheet and book value. SpaceX has become a focal point in the debate over how much investors should pay for hard assets like rockets, satellites, data centers and AI infrastructure when the story is moving this fast. Over the past month the stock has gained about 9.4%, which puts fresh pressure on...

Marriott Vacations Worldwide (VAC) has drawn investor attention after recent share moves that left the price around $103. Short term returns have been mixed, with gains over the past 3 months but a weaker month. Over the past year, momentum in Marriott Vacations Worldwide has shifted from a sharp rebound to a cooler phase. The 1-year total shareholder return of 40.99% and year-to-date share price return of 75.06% are now giving way to a 30-day share price decline of 11.19% and a softer 1-week...

Amneal Pharmaceuticals reported that the FDA approved its lanreotide injection 120 mg/0.5 mL as a sterile, single dose prefilled syringe, referencing SOMATULINE Depot, with immediate U.S. launch and Competitive Generic Therapy designation in a market where branded sales were US$983 million for the 12 months to July 2026. The lanreotide approval gives Amneal Pharmaceuticals a complex injectable in endocrinology and oncology. This may deepen its Affordable Medicines portfolio in acromegaly,...

Recent industry research has put Q2 Holdings (QTWO) in the spotlight as banks and fintechs ramp up spending on digital banking platforms, fraud controls, and AI-driven compliance tools. Q2 Holdings has had a choppy run, with the share price at US$58.73 after a 1-day share price return of 1.35%. The 30-day share price return is down 8.35%, while the 90-day share price return of 37.06% and the 3-year total shareholder return of 84.51% point to momentum that has emerged over longer periods. At...

We'd be surprised if Chemung Financial Corporation ( NASDAQ:CHMG ) shareholders haven't noticed that the Executive VP...

Quite a few insiders have dramatically grown their holdings in Betterware de México, S.A.P.I. de C.V. ( NYSE:BWMX...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Warnings from leading AI lab executives about catastrophic risks have not stopped money flowing into big technology stocks. Markets have taken these headlines in stride, treating AI tail risk as background noise rather than a reason to run for havens like US Treasuries, the dollar, or gold. That gap between existential worry and investor behavior is where some investors may see opportunity. This article breaks down three large AI focused leaders exposed to this news theme and explains how...

Tesla (TSLA) is back in focus as investors weigh its high valuation against fresh signals from the Morgan Stanley Laguna Conference and the ongoing robotaxi and Cybercab rollout under tighter U.S. safety scrutiny. Recent headlines around robotaxis, the Cybercab inquiry and new chip and solar projects have not prevented Tesla’s 1-month share price return of 5.55% from standing in contrast to a year-to-date decline of 16.85%, while the 3-year total shareholder return of 48.75% still reflects...

Jefferies Financial Group (JEF) is back in focus after Oppenheimer highlighted rising demand for its advisory and underwriting work, pointing investors toward the group’s investment banking and capital markets outlook. Jefferies Financial Group’s share price has pulled back to US$47.90, with the stock falling about 11% over the past month and roughly 25% year to date. However, the 3-year total shareholder return of about 40% and 5-year total shareholder return of about 56% point to stronger...

Boeing (BA) is back in the cargo spotlight after AerSale agreed to lease a Boeing 757-200PCF freighter to Jupiter Jet, a Kazakhstan based carrier that is expanding regional and international freight routes. For investors tracking Boeing, that new 757-200PCF lease lands against a softer backdrop, with the share price at about $198.20, a 30 day share price return down 10.8%, and a 1 year total shareholder return down 8.1%, which points to fading momentum despite ongoing cargo, defense and...